Soxman Pharmaceuticals files suit against Par Pharmaceutical over one patent related to a method for providing sleep therapy comprising administering a 3 mg or a 6 mg dose of doxepin to an individual at least three hours after consuming a meal. 5/26, District of Delaware, 1:2011cv00476.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
